Literature DB >> 4730177

Influence of tumour growth on the evolution of cytotoxic lymphoid cells in rats bearing a spontaneously metastasizing syngeneic fibrosarcoma.

G A Currie, J O Gage.   

Abstract

Regional and distant lymph node cells, thoracic duct cells and peripheral blood lymphocytes from rats bearing a spontaneously metastasizing and apparently non-immunogenic sarcoma were assayed for cytotoxic activity on microcultures of tumour cells at 7, 14 and 21 days of tumour growth. In the regional lymph nodes detectable cytotoxicity was present at 7 days and the overall activity remained constant at 14 and 21 days. At Day 7 of tumour growth the cytotoxic cell population in the regional node was tumour specific in its cytotoxic effect, very radiosensitive and could not be removed by nylon wool column purification. In contrast the cells in the regional nodes at Day 21 were nonspecifically cytotoxic and could be completely removed by nylon wool treatment. In the peripheral blood, cytotoxic lymphoid cells not removed by nylon wool, were detectable at all stages of tumour growth. The thoracic duct lymph cells were, however, without cytotoxic activity throughout the period of tumour growth studied. Distant lymph node cells were assayed for cytotoxicity and it was found that they acquired significant cytocidal properties only late in tumour growth. The sera from tumour-bearing rats were tested for inhibitory activity on the cytotoxicity of Day 7 regional lymph nodes from tumour-bearing rats. It was found that a specific inhibitor appeared in the serum and that its activity increased with tumour growth. The possible contributions of the changes in lymph node cytotoxicity and the development of specific serum inhibitors to continued growth and dissemination of the tumour are discussed.

Entities:  

Mesh:

Year:  1973        PMID: 4730177      PMCID: PMC2008890          DOI: 10.1038/bjc.1973.131

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  Mechanism of immunologically specific killing of tumour cells by macrophages.

Authors:  R Evans; P Alexander
Journal:  Nature       Date:  1972-03-24       Impact factor: 49.962

2.  The cellular immune response to primary sarcomata in rats. II. Abnormal responses of nodes draining the tumour.

Authors:  P Alexander; J Bensted; E J Delorme; J G Hall; J Hodgett
Journal:  Proc R Soc Lond B Biol Sci       Date:  1969-11-18

3.  A factor preventing the development of lung metastases in rats with sarcomas.

Authors:  J W Proctor; C M Rudenstam; P Alexander
Journal:  Nature       Date:  1973-03-02       Impact factor: 49.962

4.  Host immunity to a growing transplanted methylcholanthrene-induced guinea pig sarcoma.

Authors:  A M Cohen; R C Millar; A S Ketcham
Journal:  Cancer Res       Date:  1972-11       Impact factor: 12.701

5.  Immune response to Gross virus-induced lymphoma. 3. Characteristics of the cellular immune response.

Authors:  M O De Landazuri; R B Herberman
Journal:  J Natl Cancer Inst       Date:  1972-07       Impact factor: 13.506

6.  A microassay for cell-mediated immunity.

Authors:  M Takasugi; E Klein
Journal:  Transplantation       Date:  1970-03       Impact factor: 4.939

7.  The role of the regional lymph nodes in the immunity to a chemically induced sarcoma in C3H mice.

Authors:  D S Bard; W G Hammond; Y H Pilch
Journal:  Cancer Res       Date:  1969-07       Impact factor: 12.701

8.  Evidence for an immunological reaction of the host directed against its own actively growing primary tumor.

Authors:  Z B Mikulska; C Smith; P Alexander
Journal:  J Natl Cancer Inst       Date:  1966-01       Impact factor: 13.506

9.  In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen.

Authors:  E W Lamon; H M Skurzak; E Klein; H Wigzell
Journal:  J Exp Med       Date:  1972-11-01       Impact factor: 14.307

10.  Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen.

Authors:  G A Currie; C Basham
Journal:  Br J Cancer       Date:  1972-12       Impact factor: 7.640

View more
  26 in total

1.  Correlation between tumour blood flow and fluorouracil distribution in a hypovascular liver metastasis model.

Authors:  D Burke; P Carnochan; C Glover; T G Allen-Mersh
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by Simian immunodeficiency virus.

Authors:  P R Clapham; D Blanc; R A Weiss
Journal:  Virology       Date:  1991-04       Impact factor: 3.616

3.  Clearance of antibodies from rat sarcoma cell surfaces. Rate of clearance of alloantibodies depends on antibody isotype.

Authors:  S M Hobbs; J M Styles; C J Dean; P S Shepherd
Journal:  Immunology       Date:  1983-12       Impact factor: 7.397

4.  Tumour blood flow modification by endothelin-related peptides in the rat HSN fibrosarcoma.

Authors:  K M Bell; V E Prise; D J Chaplin; G M Tozer
Journal:  Br J Cancer Suppl       Date:  1996-07

5.  The spread of cancer in the organism. Facts and problems.

Authors:  P Sträuli
Journal:  Naturwissenschaften       Date:  1977-08

6.  Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus.

Authors:  S J Russell; A Brandenburger; C L Flemming; M K Collins; J Rommelaere
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

7.  Monoclonal antibodies to rat sarcomata. II. A syngeneic IgG2b antibody with anti-tumour activity.

Authors:  S M North; C J Dean
Journal:  Immunology       Date:  1983-08       Impact factor: 7.397

8.  The production of hybridomas from the gut associated lymphoid tissue of tumour bearing rats. I. Mesenteric nodes as a source of IgG producing cells.

Authors:  C J Dean; J M Styles; L A Gyure; J Peppard; S M Hobbs; E Jackson; J G Hall
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

9.  Monoclonal antibodies to rat sarcomata. I. Immunization procedures and source of lymphoid cells for hybridoma production.

Authors:  S M North; J M Styles; S M Hobbs; C J Dean
Journal:  Immunology       Date:  1982-11       Impact factor: 7.397

10.  Reduced glycosylation of human cell lines increases susceptibility to CD4-independent infection by human immunodeficiency virus type 2 (LAV-2/B).

Authors:  S J Talbot; R A Weiss; T F Schulz
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.